No Data
No Data
The Market Doesn't Like What It Sees From Intco Medical Technology Co., Ltd.'s (SZSE:300677) Earnings Yet
Intco Medical Technology (300677.SZ) mainly uses clean coal, which further reduces the company's energy consumption costs compared to competitors who use henry hub natural gas, steam, and other energy sources.
On July 24th, InTco Medical Technology (300677.SZ) expressed on the investor interaction platform that, as a global leader in the disposable glove industry, the company has continuously strengthened its advantages upstream and downstream in the industry chain, and continuously carried out cost-saving and efficiency-increasing work in all aspects. After the first quarter report, cost advantages are highlighted. First, based on years of equipment integration experience and continuous improvement and innovation, the company has built the third generation production line through independent research and development. On the basis of ensuring product quality, it has industry-leading production line speed, lower energy consumption, and lower weight control level. Second, in terms of energy, the company mainly uses clean energy.
Intco Medical Technology (300677.SZ): The company's overseas orders are mainly in the form of FOB orders, and the marine transportation costs are borne by the customer.
Intco Medical Technology (300677.SZ) stated on the investor interaction platform on July 24th that its overseas orders are mainly in the form of FOB orders, and marine transportation costs are borne by the customers. At the same time, the company has signed a long-term stable strategic cooperation agreement with top marine transportation groups, and the company's support department actively utilizes company resources to help customers find suitable shipping solutions, fully ensuring high-level service quality for customers.
Since the beginning of this year, Intco Medical Technology (300677.SZ) has maintained full production and sales with a lead time of 2-3 months for orders.
Intco Medical Technology (300677.SZ) said on the investor interaction platform on July 24 that from the second half of 2023, the inventory backlog in the downstream of the industry has entered the final digestion stage. The effect of clearing high-cost and outdated production capacity has become apparent, and the concentration of the industry's supply side has increased. The overall production capacity utilization rate of the industry's leading enterprises has generally increased, and the supply-demand relationship has gradually returned to a balanced trend. Since the beginning of this year, the company has maintained full production and sales, with a lead time of 2-3 months and a slight increase in the price of disposable gloves compared to the previous period.
Intco Medical Technology's H1 Profit to Soar Up to 112%
Intco Medical Technology: 2024 Interim Performance Forecast
No Data